Relmada Therapeutics (RLMD) Stock Chart & Stock Price History $2.01 0.00 (0.00%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$2.03 +0.02 (+1.00%) As of 10/17/2025 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Relmada Therapeutics Stock Price Performance The Relmada Therapeutics (RLMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.32%, with a year-to-date return of 286.54%. In the past month, the stock has increased 21.82%, reflecting recent market activity. As of the latest close, Relmada Therapeutics traded at $2.01 with a market cap of $66.71 million and volume of 222,853 shares. Five years ago, the stock traded at $34.86, representing a 94.23% decrease over that period. At the time, it had a market cap of $558.60 million and a volume of 110,486 shares. Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.50%1 Month Performance+21.82%3 Month Performance+248.35%Year-To-Date Performance+286.54%1 Year Performance-44.32%5 Year Performance-94.23% RLMD Stock Chart for Saturday, October, 18, 2025 RLMD Chart by TradingView Relmada Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2025$2.01$2.01$2.01$1.80222,853 shs$66.71 million10/16/2025$2.07$2.01-2.90%$2.10$1.90200,638 shs$66.72 million10/15/2025$1.93$2.07+7.25%$2.14$1.93298,793 shs$68.70 million10/14/2025$2.02$1.93-4.46%$2.03$1.87171,457 shs$64.06 million10/13/2025$2.04$2.02-0.98%$2.08$1.92151,419 shs$67.05 million10/10/2025$2.20$2.04-7.27%$2.24$1.97216,866 shs$67.71 million10/09/2025$2.13$2.20+3.29%$2.27$2.06363,635 shs$73.02 million10/08/2025$1.99$2.13+7.04%$2.14$1.96292,852 shs$70.70 million10/07/2025$2.08$1.99-4.33%$2.17$1.92257,444 shs$66.05 million10/06/2025$2.32$2.08-10.34%$2.42$1.89657,925 shs$69.04 million10/03/2025$2.66$2.32-12.78%$2.84$2.13972,178 shs$77.00 million10/02/2025$2.16$2.66+23.15%$2.80$2.16918,482 shs$88.29 million10/01/2025$2.01$2.16+7.46%$2.19$1.97405,374 shs$71.70 million09/30/2025$1.88$2.01+6.91%$2.09$1.90452,532 shs$66.71 million09/29/2025$1.81$1.88+3.87%$2.05$1.78389,947 shs$62.40 million09/26/2025$1.66$1.81+9.04%$1.81$1.62349,105 shs$60.07 million09/25/2025$1.65$1.66+0.61%$1.68$1.53242,906 shs$55.10 million09/24/2025$1.67$1.65-1.20%$1.71$1.56173,174 shs$54.76 million09/23/2025$1.65$1.67+1.21%$1.75$1.59313,670 shs$55.43 million09/22/2025$1.53$1.65+7.84%$1.67$1.47397,486 shs$54.77 million09/19/2025$1.65$1.53-7.27%$1.70$1.50316,532 shs$50.78 million09/18/2025$1.51$1.65+9.27%$1.68$1.52425,793 shs$54.76 million09/17/2025$1.60$1.51-5.63%$1.65$1.50265,379 shs$50.12 million Related Companies Candel Therapeutics Stock Price Chart scPharmaceuticals Stock Price Chart Alpha Teknova Stock Price Chart SOPHiA GENETICS Stock Price Chart Neumora Therapeutics Stock Price Chart Allogene Therapeutics Stock Price Chart Jade Biosciences Stock Price Chart Tectonic Therapeutic Stock Price Chart Abeona Therapeutics Stock Price Chart Galectin Therapeutics Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLMD Stock Alerts